SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Sun Nan)
 

Sökning: WFRF:(Sun Nan) > Sequencing of 640,0...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00006810naa a2201021 4500
001oai:lup.lub.lu.se:3d414414-f96d-407d-ac3f-ba33611f898e
003SwePub
008210823s2021 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/3d414414-f96d-407d-ac3f-ba33611f898e2 URI
024a https://doi.org/10.1126/science.abf86832 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Akbari, Parsau Regeneron Pharmaceuticals, Inc.4 aut
2451 0a Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity
264 1b American Association for the Advancement of Science (AAAS),c 2021
520 a Large-scale human exome sequencing can identify rare protein-coding variants with a large impact on complex traits such as body adiposity. We sequenced the exomes of 645,626 individuals from the United Kingdom, the United States, and Mexico and estimated associations of rare coding variants with body mass index (BMI). We identified 16 genes with an exome-wide significant association with BMI, including those encoding five brain-expressed G protein-coupled receptors (CALCR, MC4R, GIPR, GPR151, and GPR75). Protein-truncating variants in GPR75 were observed in ∼4/10,000 sequenced individuals and were associated with 1.8 kilograms per square meter lower BMI and 54% lower odds of obesity in the heterozygous state. Knock out of Gpr75 in mice resulted in resistance to weight gain and improved glycemic control in a high-fat diet model. Inhibition of GPR75 may provide a therapeutic strategy for obesity.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng
700a Gilani, Ankitu New York Medical College4 aut
700a Sosina, Olukayodeu Regeneron Pharmaceuticals, Inc.4 aut
700a Kosmicki, Jack A.u Regeneron Pharmaceuticals, Inc.4 aut
700a Khrimian, Loriu Regeneron Pharmaceuticals, Inc.4 aut
700a Fang, Yi Yau Regeneron Pharmaceuticals, Inc.4 aut
700a Persaud, Trikaldarshiu Regeneron Pharmaceuticals, Inc.4 aut
700a Garcia, Victoru New York Medical College4 aut
700a Sun, Dylanu Regeneron Pharmaceuticals, Inc.4 aut
700a Li, Alexanderu Regeneron Pharmaceuticals, Inc.4 aut
700a Mbatchou, Joelleu Regeneron Pharmaceuticals, Inc.4 aut
700a Locke, Adam E.u Regeneron Pharmaceuticals, Inc.4 aut
700a Benner, Christianu Regeneron Pharmaceuticals, Inc.4 aut
700a Verweij, Nieku Regeneron Pharmaceuticals, Inc.4 aut
700a Lin, Nanu Regeneron Pharmaceuticals, Inc.4 aut
700a Hossain, Sakibu New York Medical College4 aut
700a Agostinucci, Kevinu New York Medical College4 aut
700a Pascale, Jonathan V.u New York Medical College4 aut
700a Dirice, Ercumentu New York Medical College4 aut
700a Dunn, Michaelu Regeneron Pharmaceuticals, Inc.4 aut
700a Kraus, William E.u Duke University Medical Center4 aut
700a Shah, Svati H.u Duke University Medical Center4 aut
700a Chen, Yii Der I.u University of California, Los Angeles4 aut
700a Rotter, Jerome I.u University of California, Los Angeles4 aut
700a Rader, Daniel J.u University of Pennsylvania4 aut
700a Melander, Olleu Lund University,Lunds universitet,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Cardiovascular Research - Hypertension,Lund University Research Groups,Skåne University Hospital4 aut0 (Swepub:lu)endo-ome
700a Still, Christopher D.u Geisinger Health System4 aut
700a Mirshahi, Tooraju Geisinger Health System4 aut
700a Carey, David J.u Geisinger Health System4 aut
700a Berumen-Campos, Jaimeu National Autonomous University of Mexico4 aut
700a Kuri-Morales, Pablou National Autonomous University of Mexico4 aut
700a Alegre-Díaz, Jesusu National Autonomous University of Mexico4 aut
700a Torres, Jason M.u University of Oxford4 aut
700a Emberson, Jonathan R.u University of Oxford4 aut
700a Collins, Roryu University of Oxford4 aut
700a Balasubramanian, Suganthiu Regeneron Pharmaceuticals, Inc.4 aut
700a Hawes, Aliciau Regeneron Pharmaceuticals, Inc.4 aut
700a Jones, Marcusu Regeneron Pharmaceuticals, Inc.4 aut
700a Zambrowicz, Brianu Regeneron Pharmaceuticals, Inc.4 aut
700a Murphy, Andrew J.u Regeneron Pharmaceuticals, Inc.4 aut
700a Paulding, Charlesu Regeneron Pharmaceuticals, Inc.4 aut
700a Coppola, Giovanniu Regeneron Pharmaceuticals, Inc.4 aut
700a Overton, John D.u Regeneron Pharmaceuticals, Inc.4 aut
700a Reid, Jeffrey G.u Regeneron Pharmaceuticals, Inc.4 aut
700a Shuldiner, Alan R.u Regeneron Pharmaceuticals, Inc.4 aut
700a Cantor, Michaelu Regeneron Pharmaceuticals, Inc.4 aut
700a Kang, Hyun M.u Regeneron Pharmaceuticals, Inc.4 aut
700a Abecasis, Goncalo R.u Regeneron Pharmaceuticals, Inc.4 aut
700a Karalis, Katiau Regeneron Pharmaceuticals, Inc.4 aut
700a Economides, Aris N.u Regeneron Pharmaceuticals, Inc.4 aut
700a Marchini, Jonathanu Regeneron Pharmaceuticals, Inc.4 aut
700a Yancopoulos, George Du Regeneron Pharmaceuticals, Inc.4 aut
700a Sleeman, Mark W.u Regeneron Pharmaceuticals, Inc.4 aut
700a Altarejos, Judithu Regeneron Pharmaceuticals, Inc.4 aut
700a Gatta, Giusy Dellau Regeneron Pharmaceuticals, Inc.4 aut
700a Tapia-Conyer, Robertou National Autonomous University of Mexico4 aut
700a Schwartzman, Michal L.u New York Medical College4 aut
700a Baras, Arisu Regeneron Pharmaceuticals, Inc.4 aut
700a Ferreira, Manuel A. R.u Regeneron Pharmaceuticals, Inc.4 aut
700a Lotta, Luca A.u Regeneron Pharmaceuticals, Inc.4 aut
710a Regeneron Pharmaceuticals, Inc.b New York Medical College4 org
710a Regeneron Genetics Center
710a DiscovEHR Collaboration
773t Scienced : American Association for the Advancement of Science (AAAS)g 373:6550q 373:6550x 0036-8075x 1095-9203
856u http://dx.doi.org/10.1126/science.abf8683y FULLTEXT
856u https://www.ukbiobank.ac.uk/media/ezrderzw/applicant-mta.pdf
8564 8u https://lup.lub.lu.se/record/3d414414-f96d-407d-ac3f-ba33611f898e
8564 8u https://doi.org/10.1126/science.abf8683

Hitta via bibliotek

  • Science (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy